| Autor: |
Shimbo, Daichi, Shah, Rashmee U., Abdalla, Marwah, Agarwal, Ritu, Ahmad, Faraz S., Anaya, Gabriel, Attia, Zachi I., Bull, Sheana, Chang, Alexander R., Commodore-Mensah, Yvonne, Ferdinand, Keith, Kawamoto, Kensaku, Khera, Rohan, Leopold, Jane, Luo, James, Makhni, Sonya, Mortazavi, Bobak J., Oh, Young S., Savage, Lucia C., Spatz, Erica S. |
| Zdroj: |
Hypertension (0194911X); Jan2025, Vol. 82 Issue 1, p36-45, 10p |
| Abstrakt: |
Hypertension is among the most important risk factors for cardiovascular disease, chronic kidney disease, and dementia. The artificial intelligence (AI) field is advancing quickly, and there has been little discussion on how AI could be leveraged for improving the diagnosis and management of hypertension. AI technologies, including machine learning tools, could alter the way we diagnose and manage hypertension, with potential impacts for improving individual and population health. The development of successful AI tools in public health and health care systems requires diverse types of expertise with collaborative relationships between clinicians, engineers, and data scientists. Unbiased data sources, management, and analyses remain a foundational challenge. From a diagnostic standpoint, machine learning tools may improve the measurement of blood pressure and be useful in the prediction of incident hypertension. To advance the management of hypertension, machine learning tools may be useful to find personalized treatments for patients using analytics to predict response to antihypertension medications and the risk for hypertension-related complications. However, there are real-world implementation challenges to using AI tools in hypertension. Herein, we summarize key findings from a diverse group of stakeholders who participated in a workshop held by the National Heart, Lung, and Blood Institute in March 2023. Workshop participants presented information on communication gaps between clinical medicine, data science, and engineering in health care; novel approaches to estimating BP, hypertension risk, and BP control; and real-world implementation challenges and issues. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
